Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema (left eye)
ICD-10 E09.3512 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema (left eye).
E09.3512 refers to diabetes mellitus that has been induced by drugs or chemicals, leading to significant complications such as proliferative diabetic retinopathy and macular edema specifically in the left eye. Drug-induced diabetes can occur due to various medications, including corticosteroids, antipsychotics, and certain antiretrovirals, which can impair insulin secretion or action. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels in the retina, which can lead to vision loss. Macular edema, a common complication, results from fluid accumulation in the macula, causing blurred vision. Management of this condition often involves controlling blood glucose levels, monitoring HbA1c levels, and potentially using insulin therapy or other antidiabetic medications. Regular eye examinations are crucial for early detection and treatment of retinopathy and edema.
Detailed medication history, HbA1c levels, and treatment plans.
Management of drug-induced diabetes and monitoring for complications.
Ensure accurate documentation of the drug causing diabetes and its management.
Visual acuity tests, retinal examination findings, and treatment plans for retinopathy.
Evaluation and treatment of diabetic retinopathy and macular edema.
Document specific findings related to the left eye and treatment interventions.
Used during follow-up visits for diabetic retinopathy management.
Document visual acuity, retinal findings, and treatment plans.
Ophthalmologists should ensure detailed documentation of eye health.
Medications such as corticosteroids, certain antipsychotics, and some antiretrovirals are known to potentially induce diabetes by affecting insulin secretion or action.
